U.S Physical Therapy Net Long-Term Debt 2010-2025 | USPH

U.S Physical Therapy net long-term debt from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
U.S Physical Therapy Annual Net Long-Term Debt
(Millions of US $)
2024 $4
2023 $-39
2022 $64
2021 $93
2020 $-31
2019 $7
2018 $-20
2017 $7
2016 $1
2015 $9
2014 $-6
2013 $22
2012 $-7
2011 $18
2010 $4
2009 $-12
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.206B $0.671B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.898B 19.61
Encompass Health (EHC) United States $12.270B 26.01
DaVita (DVA) United States $11.006B 15.48
Chemed (CHE) United States $8.507B 26.74
Elanco Animal Health (ELAN) United States $6.496B 13.91
Option Care Health (OPCH) United States $5.415B 24.14
RadNet (RDNT) United States $4.514B 286.48
Amedisys (AMED) United States $3.109B 20.91
LifeStance Health (LFST) United States $2.267B 0.00
Addus HomeCare (ADUS) United States $2.070B 22.73
Astrana Health (ASTH) United States $1.518B 37.61
Aveanna Healthcare Holdings (AVAH) United States $1.122B 63.89
Pennant (PNTG) United States $1.014B 37.25
Atai Life Sciences (ATAI) Germany $0.411B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.037B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00